The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
UCLA Microbiome Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Nutrients. 2020 Oct 21;12(10):3221. doi: 10.3390/nu12103221.
High protein calorie restriction diets have shown clinical efficacy for obesity, but the mechanisms are not fully known. The intestinal microbiome is a mediator of obesity and preclinical data support an effect of high protein diet (HPD) on the gut microbiome of obesity, but there are few studies in humans.
To address this, we conducted a dietary intervention trial of 80 overweight and obese subjects who were randomized to a calorie-restricted high protein diet (HPD) (30% calorie intake) or calorie-restricted normal protein diet (NPD) (15%) for 8 weeks. Baseline dietary intake patterns were assessed by the Diet History Questionnaire III. Longitudinal fecal sampling was performed at baseline, week 1, week 2, week 4, week 6, and week 8, for a total of 365 samples. Intestinal microbiome composition was assessed by 16S rRNA gene sequencing.
At baseline, microbial composition was associated with fiber and protein intake. Subjects on the HPD showed a significant increase in microbial diversity as measured by the Shannon index compared to those on the NPD. The HPD was also associated with significant differences in microbial composition after treatment compared to the NPD. Both diets induced taxonomic shifts compared to baseline, including enrichment of and and depletion of Conclusion: These findings provide evidence that weight loss diets alter the gut microbiome in obesity and suggest differential effects of HPDs compared to NPDs which may influence the clinical response to HPD.
高蛋白热量限制饮食已显示出对肥胖的临床疗效,但具体机制尚不完全清楚。肠道微生物群是肥胖的中介物,临床前数据支持高蛋白饮食(HPD)对肥胖人群肠道微生物群的影响,但在人类中研究较少。
为了解决这个问题,我们对 80 名超重和肥胖受试者进行了饮食干预试验,这些受试者被随机分配到热量限制高蛋白饮食(HPD)(30%的热量摄入)或热量限制正常蛋白饮食(NPD)(15%),持续 8 周。基线膳食摄入模式通过饮食史问卷 III 进行评估。在基线、第 1 周、第 2 周、第 4 周、第 6 周和第 8 周进行纵向粪便采样,共采集 365 个样本。通过 16S rRNA 基因测序评估肠道微生物组组成。
在基线时,微生物组成与纤维和蛋白质摄入有关。与 NPD 相比,接受 HPD 的受试者的微生物多样性(用 Shannon 指数衡量)显著增加。与 NPD 相比,HPD 治疗后微生物组成也有显著差异。与基线相比,两种饮食都引起了分类群的变化,包括 和 的富集和 的消耗。
这些发现提供了证据表明,减肥饮食会改变肥胖人群的肠道微生物群,并表明 HPD 与 NPD 相比可能会产生不同的影响,从而影响 HPD 的临床反应。